969084.fig.005a
(a)
969084.fig.005b
(b)
Figure 5: The prognostic role of p130cas expression in breast carcinoma effusions. (a): Kaplan-Meier survival curve showing the trend for association between p130cas expression and overall survival (OS) for 44 patients with breast carcinoma effusions. Patients with effusions with higher expression (>25% of tumor cells) (n=33, dashed line) had a mean OS of 78 months versus 142 months for patients whose effusions showed low (25%) expression (n=11, solid line; P=.062). (b): Kaplan-Meier survival curve showing the trend for association between p130cas expression and disease-free survival (DFS) for 42 patients with breast carcinoma effusions. Patients with effusions with higher expression (>25% of tumor cells) (n=31, dashed line) had a mean DFS of 48 months versus 89 months for patients whose effusions showed low (25%) expression (n=11, solid line; P=.098). DFS data were unavailable for 2 patients.